Please use this identifier to cite or link to this item: http://10.9.150.37:8080/dspace//handle/atmiyauni/1121
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBuddhadev, Sheetal-
dc.contributor.authorGarala, Kevin-
dc.date.accessioned2023-05-27T02:49:32Z-
dc.date.available2023-05-27T02:49:32Z-
dc.date.issued2020-11-
dc.identifier.citationBuddhadev, S. ,Garala, K. ,Pharmaceutical Cocrystals—A Review †. Proceedings Journals (MDPI), Proceedings 2020, 62, 14; doi:10.3390/proceedings2020062014en_US
dc.identifier.issn2504-3900-
dc.identifier.urihttp://10.9.150.37:8080/dspace//handle/atmiyauni/1121-
dc.descriptionWriter is grateful to Noble Pharmacy College and Atmiya Institute of Pharmacy for their continuous support.en_US
dc.description.abstractThe design and synthesis of pharmaceutical cocrystals have received great interest in the recent years. Cocrystallization of drug substances offers a tremendous opportunity for the development of new drug products with superior physical and pharmacological properties such as solubility, stability, hydroscopicity, dissolution rates and bioavailability. This short review summarizes this highly topical field, covering why the topic is of interest in pharmaceutical formulation, the definitions and practical scope of cocrystals, cocrystal preparation and characterization, a comparison of different (traditional and novel) methods for cocrystal formation and the implications for regulatory control and intellectual property protection. Traditionally, cocrystals can be prepared by solvent evaporation method, grinding, and slurry method, but every method has its limitations for certain conditions. The current trend for cocrystal formation uses sophisticated methods such as the hot melt extrusion method, spray-drying method, supercritical fluid technology and the newest method: laser irradiation. The purpose of the development of a new method is not only to overcome the limitation of traditional cocrystallization methods, but also to generate simpler steps and a continuous process for the production of the cocrystal product. This article provides a brief explanation of each method that can be used to generate pharmaceutical cocrystals as well as evaluation of cocrystals. This article also covers how the developing field of cocrystallization may impact the pharmaceutical intellectual property landscape.en_US
dc.language.isoenen_US
dc.publisherProceedings Journals (MDPI)en_US
dc.subjectpharmaceutical cocrystals (PC)en_US
dc.subjectcocrystallizationen_US
dc.subjectactive pharmaceutical ingredient (API)en_US
dc.subjectgenerally recognized as safe (GRAS)en_US
dc.subjectcocrystal former (CF)en_US
dc.subjectnovel methodsen_US
dc.subjecttraditional methodsen_US
dc.titlePharmaceutical Cocrystals—A Review †en_US
dc.typeArticleen_US
Appears in Collections:01. Journal Articles

Files in This Item:
File Description SizeFormat 
987) 23661_Kevin Chandulal Garala.pdf586.41 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.